Importance of improved TB diagnostics in addressing the extensively drug-resistant TB crisis (Q40066961)

17 September 2017

Importance of improved TB diagnostics in addressing the extensively drug-resistant TB crisis (English)

1 reference

17 September 2017

Nicole Parrish

1

1 reference

PubMed ID

18651812

17 September 2017

Karen Carrol

series ordinal

2

1 reference

17 September 2017

1 August 2008

1 reference

17 September 2017

9

1 reference

based on heuristic

inferred from page(s)

published in

Future Microbiology

1 reference

17 September 2017

3

1 reference

17 September 2017

4

1 reference

17 September 2017

405-413

1 reference

Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project

17 September 2017

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.405

Modeling epidemics of multidrug-resistant M. tuberculosis of heterogeneous fitness

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.405

The emergence of drug-resistant tuberculosis in New York City

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.405

Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.405

Fluoroquinolone Resistance in Patients with Newly Diagnosed Tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.405

The Rapid Development of Fluoroquinolone Resistance inM. tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.405

Extensively drug-resistant tuberculosis in sub-Saharan Africa: an emerging public-health concern.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.405

Multidrug-resistant and extensively drug-resistant tuberculosis: implications for the HIV epidemic and antiretroviral therapy rollout in South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.405

The evolution of extensively drug resistant tuberculosis (XDR-TB): history, status and issues for global control

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.405

Negative sputum smear results in HIV-positive patients with pulmonary tuberculosis in Lusaka, Zambia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.405

Improving sensitivity of direct microscopy for detection of acid-fast bacilli in sputum: use of chitin in mucus digestion

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.405

Evaluation of the phenol ammonium sulfate sedimentation smear microscopy method for diagnosis of pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.405

Fluorescence versus conventional sputum smear microscopy for tuberculosis: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.405

Sputum processing methods to improve the sensitivity of smear microscopy for tuberculosis: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.405

Facing the crisis: improving the diagnosis of tuberculosis in the HIV era.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.405

Newer diagnostics for tuberculosis and multi-drug resistant tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.405

Evaluation of the BACTEC MGIT 960 in comparison with BACTEC 460 TB for detection and recovery of mycobacteria from clinical specimens.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.405

Comparison of MB/Bact alert 3D system with radiometric BACTEC system and Löwenstein-Jensen medium for recovery and identification of mycobacteria from clinical specimens: a multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.405

Nonconventional and new methods in the diagnosis of tuberculosis: feasibility and applicability in the field

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.405

Molecular genetic methods for diagnosis and antibiotic resistance detection of mycobacteria from clinical specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.405

Molecular detection of antimicrobial resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.405

Rifampicin resistance in tuberculosis outbreak, London, England

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.405

Genotypic analysis of Mycobacterium tuberculosis in two distinct populations using molecular beacons: implications for rapid susceptibility testing

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.405

Performance of the microscopic observation drug susceptibility assay in drug susceptibility testing for Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.405

Rapid, standardized method for determination of Mycobacterium tuberculosis drug susceptibility by use of mycolic acid analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.405

21 January 2018

Identifiers

DOI

10.2217/17460913.3.4.405

1 reference

17 September 2017

1 reference

PubMed ID

18651812